STAT3 and neoplasm: STAT3 is often over-activated in tumor-infiltrating immune cells, negatively regulating neutrophils, natural killer cells, effector T-cells, and dendritic cells, while positively regulating regulatory T-cells and myeloid-derived suppressor cell (MDSC) populations (96), thereby affecting immune function.